A. Arranz-Romera

Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina

I. Bravo-Osuna, R. Herrero-Vanrell, V. Andrés-Guerrero, 2018, Advanced drug delivery reviews.

Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats

I. Bravo-Osuna, R. Herrero-Vanrell, I. Pinilla, 2017, PloS one.

A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies

I. Bravo-Osuna, R. Herrero-Vanrell, B. Tucker, 2021, Pharmaceuticals.

Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice

I. Bravo-Osuna, R. Herrero-Vanrell, M. Young, 2018, Molecular vision.

Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

I. Bravo-Osuna, R. Herrero-Vanrell, I. Molina-Martínez, 2021, Drug Delivery and Translational Research.

Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases.

I. Bravo-Osuna, R. Herrero-Vanrell, A. Arranz-Romera, 2019, Drug discovery today.

Simultaneous co‐delivery of neuroprotective drugs from multi‐loaded PLGA microspheres for the treatment of glaucoma

I. Bravo-Osuna, R. Herrero-Vanrell, B. Davis, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

I. Bravo-Osuna, R. Herrero-Vanrell, I. Molina-Martínez, 2021, Drug Delivery and Translational Research.